Registered Kenya · PPB

EMANZEN FORTE TABLETS

SERRATIOPEPTIDASE

14508 SERRATIOPEPTIDASE 10 MG/TABLET NEW/INNOVATOR INN generic

What it does

Serratiopeptidase is an enzyme that helps reduce swelling and inflammation in the body.

Commonly used for: swelling after surgery or injury, pain relief, inflammation

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
14508
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
SERRATIOPEPTIDASE
Strength
-
Pack size
5X3X10'S
Therapeutic class
NEW/INNOVATOR
Manufacturer / MAH
Lazor Pharmaceuticals
Country of origin
FOREIGN
Manufacturer location
14 Joy Avenue, Ajao Estate, Lagos 102214, Lagos, Nigeria

Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:22:10 · updated 2026-07-26 13:48:52

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Serratiopeptidase is an enzyme that helps reduce swelling and inflammation in the body.

What it treats

  • swelling after surgery or injury
  • pain relief
  • inflammation

How it works

It breaks down proteins that cause swelling and helps the body heal.

Who it's for

Adults and children who need relief from swelling and pain.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: serratiopeptidase

BNF-referenced

Serratiopeptidase, also known as serrapeptase, is a proteolytic enzyme originally derived from the silkworm. It is used for its anti-inflammatory and analgesic properties, helping to reduce pain and swelling associated with various conditions. Serratiopeptidase is believed to work by breaking down protein-based substances, including fibrin, promoting more efficient healing and reducing inflammation in affected tissues.

Indications

  • Chronic pain conditions
  • Postoperative swelling
  • Traumatic injuries
  • Sinusitis
  • Bronchitis

Dosage

Children: Refer to the BNF for Children for appropriate dosing information.

Adults: Refer to the BNF for appropriate dosing information.

Mechanism of action

Serratiopeptidase exerts its effects primarily through the breakdown of proteins and the modulation of inflammatory processes. It acts by hydrolyzing peptide bonds in proteins, which can lead to the dissolution of dead or damaged tissue and the reduction of inflammatory mediators, thus attenuating pain and swelling. This enzymatic action helps to improve tissue repair and healing.

Pharmacodynamics

The pharmacodynamics of serratiopeptidase involve its ability to modulate inflammation and pain through its proteolytic activity. By breaking down inflammatory mediators and promoting tissue healing, serratiopeptidase can enhance recovery from various inflammatory conditions. Its analgesic properties may also be attributed to the reduction of bradykinin and other inflammatory substances that contribute to pain.

Pharmacokinetics

Serratiopeptidase is absorbed in the gastrointestinal tract, with its bioavailability influenced by the presence of food. Once in the bloodstream, it distributes to tissues where it exerts its proteolytic effects. The enzyme is metabolized primarily in the liver, and its elimination half-life is variable, depending on individual patient factors. Renal function may also play a role in the clearance of serratiopeptidase and its metabolites.

Pregnancy

There is insufficient evidence regarding the safety of serratiopeptidase during pregnancy. Consult healthcare professionals before use.

Breast-feeding

Limited data are available on the excretion of serratiopeptidase in breast milk. Caution is advised when administering to nursing mothers.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Formulations

  • {'name': 'Serratiopeptidase tablet', 'strength': '10 mg', 'route': 'oral'}
  • {'name': 'Serratiopeptidase capsule', 'strength': '20 mg', 'route': 'oral'}

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: serratiopeptidase

PubChem CID 171666295

Molecular formula: C46H40N8O8

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.